Sections of Gastroenterology and Hepatology , Baylor College of Medicine , Houston , Texas , USA.
Health Services Research, Department of Medicine , Baylor College of Medicine , Houston , Texas , USA.
Hepatology. 2023 Mar 1;77(3):997-1005. doi: 10.1002/hep.32434. Epub 2023 Feb 17.
Etiological risk factors for cirrhosis have changed in the last decade. It remains unclear to what extent these trends in cirrhosis risk factors have changed HCC risk.
We used data from two contemporary, prospective multiethnic cohorts of patients with cirrhosis: the Texas Hepatocellular Carcinoma Consortium Cohort and the Houston Veterans Administration Cirrhosis Surveillance Cohort. Patients with cirrhosis were enrolled from seven US centers and followed until HCC diagnosis, transplant, death, or June 30, 2021. We calculated the annual incidence rates for HCC and examined the effects of etiology, demographic, clinical, and lifestyle factors on the risk of HCC. We included 2733 patients with cirrhosis (mean age 60.1 years, 31.3% women). At enrollment, 19.0% had active HCV, 23.3% had cured HCV, 16.1% had alcoholic liver disease, and 30.1% had NAFLD. During 7406 person-years of follow-up, 135 patients developed HCC at an annual incidence rate of 1.82% (95% CI, 1.51-2.13). The annual HCC incidence rate was 1.71% in patients with cured HCV, 1.32% in patients with alcoholic liver disease, and 1.24% in patients with NAFLD cirrhosis. Compared to patients with NAFLD, the risk of progression to HCC was 2-fold higher in patients with cured HCV (HR, 2.04; 95% CI, 1.24-3.35). Current smoking (HR, 1.63; 95% CI, 1.01-2.63) and overweight/obesity (HR, 1.79; 95% CI, 1.08-2.95) were also associated with HCC risk.
HCC incidence among patients with cirrhosis was lower than previously reported. HCC risk was variable across etiologies, with higher risk in patients with HCV cirrhosis and lower risk in those with NAFLD cirrhosis. Current smoking and overweight/obesity increased HCC risk across etiologies.
在过去的十年中,肝硬化的病因危险因素发生了变化。目前尚不清楚这些肝硬化危险因素的变化在多大程度上改变了 HCC 的风险。
我们使用了来自两个当代、前瞻性的多民族肝硬化患者队列的数据:德克萨斯州肝细胞癌联盟队列和休斯顿退伍军人事务局肝硬化监测队列。来自美国七个中心的患者被纳入研究,并随访至 HCC 诊断、移植、死亡或 2021 年 6 月 30 日。我们计算了 HCC 的年发生率,并研究了病因、人口统计学、临床和生活方式因素对 HCC 风险的影响。我们纳入了 2733 例肝硬化患者(平均年龄 60.1 岁,31.3%为女性)。在入组时,19.0%的患者有活动性 HCV,23.3%的患者 HCV 已治愈,16.1%的患者有酒精性肝病,30.1%的患者有非酒精性脂肪性肝病。在 7406 人年的随访期间,135 例患者发生 HCC,年发生率为 1.82%(95%CI,1.51-2.13)。在 HCV 已治愈的患者中,HCC 的年发生率为 1.71%,在酒精性肝病患者中为 1.32%,在非酒精性脂肪性肝病肝硬化患者中为 1.24%。与非酒精性脂肪性肝病患者相比,HCV 已治愈患者进展为 HCC 的风险增加了 2 倍(HR,2.04;95%CI,1.24-3.35)。目前吸烟(HR,1.63;95%CI,1.01-2.63)和超重/肥胖(HR,1.79;95%CI,1.08-2.95)也与 HCC 风险相关。
肝硬化患者 HCC 的发病率低于之前的报道。HCC 的风险因病因而异,HCV 肝硬化患者的风险较高,而非酒精性脂肪性肝病肝硬化患者的风险较低。目前吸烟和超重/肥胖增加了各病因 HCC 的风险。